Navigation Links
Cordex Pharma Presents 'New Frontiers in Cardiovascular Medicines' on January 29
Date:1/23/2009

LA JOLLA, Calif., Jan. 23 /PRNewswire-FirstCall/ -- Cordex Pharma, Inc., formerly known as Duska Therapeutics, Inc., (OTC Bulletin Board: DSKA) announced today that it will host a scientific briefing on Thursday, January 29, 2009, at 12:00 p.m. EST in New York City.

The keynote speaker will be Jonathan S. Stamler, MD, the George Barth Geller Professor for Research in Cardiovascular Diseases and a Professor of Medicine and of Biochemistry at Duke University Medical Center in Durham, North Carolina. Dr. Stamler will review his research work at Duke University, which focuses on the regulatory role of nitric oxide (NO) in the cardiovascular system. In particular, Dr. Stamler will outline the rationale behind the development of NO-based therapeutic modality in the management of patients with heart failure. The risk of sudden cardiac death in heart failure patients is six to nine times greater than that of the general population. Heart failure is responsible for 280,000 deaths annually in the US.

Dr. Stamler's presentation will be preceded by a short corporate overview by Cordex's chief executive officer, James S. Kuo, MD, MBA, and an update by the Company's chief scientific officer, Amir Pelleg, PhD, on the Company's lead drug candidate, ATPace, for the treatment and diagnosis of cardiac arrhythmias. Cordex expects to initiate a pivotal Phase 3 clinical trial with ATPace. The Phase 3 protocol is currently under consideration by the FDA under a Special Protocol Assessment provision.

Cordex's event will be held at the Yale Club in New York City. A buffet lunch will be provided beginning at 11:30 a.m. EST. Due to meeting room size limitations, in person attendance is by invitation only. To request an invitation, please call Redington Inc. at (212) 926-1733.

A webcast of the presentation can be accessed by any registered participants and will be made available at '/>"/>

SOURCE Cordex Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Axikin Pharmaceuticals Spins out of Actimis
2. Asbestos, Pharmaceutical Liability, Construction Defects, Nanotech: Covered by Targeted CLE Teleconferences
3. FDA Issues Complete Response Letter to SCOLR Pharmas Abbreviated New Drug Application for CDT(R) 12-Hour Pseudoephedrine
4. BioMed Realty Trust Extends Leases With Vertex Pharmaceuticals Through 2015
5. Cracking the Code: Exclusive Conference to Reveal Secrets of Chinese Pharmaceutical Industry
6. Poniard Pharmaceuticals Announces Positive Tumor Response and Neuropathy Data from Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer
7. Cumberland Pharmaceuticals Appoints Lee Product Director
8. Genesis Pharmaceuticals Appoints KPMG to Help Develop a SOX 404 Compliance Program
9. ERYtech Pharma Signs an Agreement With the Penn Jersey Region of American Red Cross
10. Keryx Biopharmaceuticals to Present at the J.P. Morgan 27th Annual Healthcare Conference
11. Alseres Pharmaceuticals, Inc. Announces $1 Million Financing

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., Nov. 24 NeurogesX, Inc...cused on developing and commercializing novel pain...y DiTonno, President and Chief Executive Officer, ...affray Health Care Conference, to be held December...k, New York. ,, Mr. DiTonno and Stephen Ghigli...
(Date:11/24/2009)...y endpoint has been met for patients with advanced... QUEBEC CITY, Nov. 24 /PRNewswire-FirstCall/ - AEt... "Company"), a global biopharmaceutical company fo...ounced positive efficacy data from a Phase 2 study...ZS-108 (formerly AN-152), in patients with advance...
(Date:11/24/2009)...., Nov. 24 Genomic Healt...y Scott, Genomic Health,s Executive Chairman, will...are Conference in New York City on Tuesday, Decemb...live and subsequently archived webcast of the pres...Genomic Health,s website at http://investor.genom...
(Date:11/24/2009)... Cell Therapeutics, Inc. ...nt at the 21st Annual Piper Jaffray Health Care Co..., 2009, at the New York Palace Hotel. ,, CTI ...Eastern Time in Holmes 1 (4th Floor). A live audio...t www.celltherapeutics.com , and it will also be ...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...THAM, Mass., April 21 Thermo Fisher,Scientific In...nce, announced,that it will present at the followi...hcare Conference on Monday, May 5, 2008, at 4:00 ..., MA., -- Bank of America Healthcare Conference o... the Four Seasons Hotel, in Las Vegas, NV., -- Ba...
... VEGAS, April 21 CardioVascular,BioTherapeutics, ... the,Over the Counter Bulletin Board (OTCBB), on w..."E" to the end of its ticker symbol. The temporary...nnual Report (Form 10-K)., Pursuant to OTCBB rule...8 provided the Company files it Annual Report befo...
...TEN, Germany, April 21 A group of German,investor...anguiBioTech,GmbH, Witten, for a purchasing price ...ctuated by way of a capital increase which will be...fective after the investment sum will,have been pa...crease will,have been entered in the German regist...
Other Biology Technology:Thermo Fisher Scientific to Present at Upcoming Investor Conferences 2Investors Acquire Share in Sangui BioTech GmbH 2
(Date:11/26/2009)...cus Aureus ) and other drug-resistant bacteria cou...totype devices have been developed to offer safe, ..., Two prototype devices have been developed: one...hands and feet) in hospitals and public spaces whe...to shoot bacteria-killing agents into infested chr...
(Date:11/25/2009)...ficers and ambulance workers faced a terrifying re...y battled to save people from the collapsing Twin ...evacuated as many people as they could in an area ...king their jobs even harder was the problem of poo...atives jammed mobile networks with calls and the e...
(Date:11/25/2009)...essors recently received funding from the National...eficial to understanding the environment. The thre..., assistant professor in the Department of Biologi...parate research projects. , His first project, t...d Functions from the Leaf to the Landscape," will ...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Magic box for mission impossible 2Magic box for mission impossible 3Kent State University professors focus research on the environment with grants totaling $890,000 2BD Announces FDA 510 28k 29 Clearance of BD Vacutainer 28R 29 Rapid Serum Blood Collection Tube 5274 1BD Announces FDA 510 28k 29 Clearance of BD Vacutainer 28R 29 Rapid Serum Blood Collection Tube 5274 2Cows Milk Protein Could Help Save Preemies Lives 58992 1Cows Milk Protein Could Help Save Preemies Lives 58992 2Cows Milk Protein Could Help Save Preemies Lives 58992 3Keeping DNA all in the family 10277 1Keeping DNA all in the family 10277 2Keeping DNA all in the family 10277 3
... of Medicine has helped confirm the reliability o...n the long-promised era of personalized medicine ...tanford group was one of the five sites that helpe...tients who are at high risk of developing cirrhos... high-risk patients could be directed toward a lon...
...l in the 29 March 2007 issue of the journal Nature...ant structures that control how genes are packaged...the first time, we are seeing in very high resolut... the expression of an organism,s genes," said B. F...lar biology and the study,s lead investigator. , T...
...of North Carolina at Chapel Hill may have identifi...nt of schizophrenia. , In studying the postmortem...h schizophrenia, the researchers found that levels...RNAs were lower among schizophrenia patients than ... , "In many genetic diseases, such as Huntington,...
Other Biology News:New test helps identify hepatitis C patients at high risk of developing cirrhosis 2New test helps identify hepatitis C patients at high risk of developing cirrhosis 3Scientists reveal structure of gateways to gene control 2Scientists reveal structure of gateways to gene control 3Scientists reveal structure of gateways to gene control 4Brain tissue reveals possible genetic trigger for schizophrenia 2
...ays can be used to test the crossreactivity of an ...e commonly used as blocking reagents or antigen ca...protein preparations on a nitrocellulose membrane....ivity and species specificity, QC of purified anti...
BAC End Sequencing from Seqwright
...ffers a full length insert sequencing service for ...mids. Agencourt utilizes unique library construct... There are several features that allow Agencourt t...turnaround including our patented magnetic bead-ba...
Bio-Plex Maintenance, Calibration, and Validation (MCV) Plate from Bio-Rad
Biology Products: